RANCHO CORDOVA, Calif., April 17, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results